Valneva SE (NAS:VALN)
$ 4.3307 0.1342 (3.2%) Market Cap: 351.65 Mil Enterprise Value: 398.38 Mil PE Ratio: 0 PB Ratio: 1.60 GF Score: 69/100

Valneva SE COVID-19 Vaccine Purchase Agreement Update Transcript

May 16, 2022 / 01:00PM GMT
Release Date Price: $19.8 (-20.51%)
Operator

Good day, and thank you for standing by. Welcome to the EC APA Update Conference Call following on from today's press release. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) And I'd now like to hand the conference over to your speaker today, Thomas Lingelbach. Please go ahead.

Thomas Lingelbach
Valneva SE - Chairman of the Management Board, President & CEO

Thank you. Good day, everyone. Well, I mean you have all seen the news. Actually, we had 2 news this morning. First one, the -- the emergency use authorization in the Emirates, UAE. But of course, the material one, that we have received notice of the European Commission's intent to terminate the COVID-19 vaccine purchase agreement, the so-called APA. And of course, the EC decision is regrettable, especially since we believe in the value of the product that we have developed thus far, the only European-developed and European-manufactured inactivated whole virus vaccine. And in the meantime, got approvals, as I said, by MHRA, by the Bahrainian

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot